| scholarly article | Q13442814 |
| P50 | author | Michael Hackenberg | Q55364037 |
| Nicoletta Zini | Q57312846 | ||
| Dirk Michiel Pegtel | Q89882139 | ||
| P2093 | author name string | Theo de Reijke | |
| Danijela Koppers-Lalic | |||
| Thomas Wurdinger | |||
| Andre Vis | |||
| Jeroen van Moorselaar | |||
| Branislav Misovic | |||
| Magda Wachalska | |||
| Albert Geldof | |||
| Irene Bijnsdorp | |||
| Renee de Menezes | |||
| P2860 | cites work | Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells | Q24607278 |
| Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer | Q24645528 | ||
| Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells | Q24646863 | ||
| Systematic review of complications of prostate biopsy | Q26822966 | ||
| MicroRNAs and their isomiRs function cooperatively to target common biological pathways | Q27499590 | ||
| edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | Q27860819 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| KRAS-dependent sorting of miRNA to exosomes | Q28646719 | ||
| Single-step isolation of extracellular vesicles by size-exclusion chromatography | Q29395319 | ||
| Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
| miRanalyzer: an update on the detection and analysis of microRNAs in high-throughput sequencing experiments | Q33880585 | ||
| PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease. | Q34025404 | ||
| Complexity of the microRNA repertoire revealed by next-generation sequencing | Q34140539 | ||
| Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. | Q34291551 | ||
| Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells | Q34299962 | ||
| Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers. | Q34482912 | ||
| Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity. | Q34495412 | ||
| Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. | Q34951363 | ||
| MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214 | Q35027675 | ||
| Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer | Q35140145 | ||
| Exosome and exosomal microRNA: trafficking, sorting, and function | Q35543884 | ||
| Dumbbell-PCR: a method to quantify specific small RNA variants with a single nucleotide resolution at terminal sequences | Q35842454 | ||
| Changes in circulating microRNA levels associated with prostate cancer | Q35879858 | ||
| Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis | Q36176766 | ||
| Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate | Q36641957 | ||
| IsomiRs--the overlooked repertoire in the dynamic microRNAome. | Q38033765 | ||
| EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. | Q38160994 | ||
| MicroRNAs in cancer: biomarkers, functions and therapy | Q38229952 | ||
| Microdissecting the role of microRNAs in the pathogenesis of prostate cancer | Q38500257 | ||
| Specific miRNA stabilization by Gld2-catalyzed monoadenylation | Q39234952 | ||
| Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer | Q39505285 | ||
| The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance | Q39786063 | ||
| Composition, associated tissue methyltransferase activity, and catabolic end products of transfer RNA from carcinogen-induced hepatoma and normal monkey livers | Q40031849 | ||
| Prostate cancer biomarker profiles in urinary sediments and exosomes. | Q40148908 | ||
| Profiling of circulating microRNAs for prostate cancer biomarker discovery. | Q40264691 | ||
| A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result | Q40311168 | ||
| Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes | Q40335169 | ||
| Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer | Q41195275 | ||
| Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes | Q42186566 | ||
| Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients | Q42775329 | ||
| A panel of five circulating microRNAs as potential biomarkers for prostate cancer | Q44430269 | ||
| miQ--a novel microRNA based diagnostic and prognostic tool for prostate cancer | Q46114858 | ||
| Re: Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8?16 | Q62632515 | ||
| False-negative Prostate Needle Biopsies: Frequency, Histopathologic Features, and Follow-up | Q63966332 | ||
| Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml | Q73383416 | ||
| P4510 | describes a project that uses | edgeR | Q113334690 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| extracellular vesicle | Q21097485 | ||
| P304 | page(s) | 22566-22578 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Non‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles | |
| P478 | volume | 7 |
| Q38854599 | Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer |
| Q64254897 | Bias-minimized quantification of microRNA reveals widespread alternative processing and 3' end modification |
| Q64061189 | Data analysis algorithm for the development of extracellular miRNA-based diagnostic systems for prostate cancer |
| Q89952887 | Direct microRNA Sequencing Using Nanopore-Induced Phase-Shift Sequencing |
| Q57476477 | Effect of exosomal miRNA on cancer biology and clinical applications |
| Q38971467 | Emerging role of microRNA-21 in cancer |
| Q55342189 | Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management. |
| Q104500575 | Extracellular heat shock proteins and cancer: New perspectives |
| Q93009737 | Extracellular vesicles in urologic malignancies-Implementations for future cancer care |
| Q91892417 | Extracellular vesicles in urological malignancies: an update |
| Q40980080 | Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method |
| Q64889875 | Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer. |
| Q42371249 | Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes |
| Q33557718 | Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types |
| Q38699922 | MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion. |
| Q39438805 | Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer |
| Q52624825 | Profiles of miRNA Isoforms and tRNA Fragments in Prostate Cancer. |
| Q28075610 | Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers |
| Q37648510 | Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer. |
| Q38702262 | Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer |
| Q60951719 | Searching for the Novel Specific Predictors of Prostate Cancer in Urine: The Analysis of 84 miRNA Expression |
| Q90017873 | Single nucleotide alterations in MicroRNAs and human cancer-A not fully explored field |
| Q99565621 | Stumbling on elusive cargo: how isomiRs challenge microRNA detection and quantification, the case of extracellular vesicles |
| Q42151262 | Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer. |
| Q92050480 | The Butterfly Effect of RNA Alterations on Transcriptomic Equilibrium |
| Q38744451 | The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical Practice. |
| Q58805122 | The Role of Extracellular Vesicles in Cancer: Cargo, Function, and Therapeutic Implications |
| Q47128288 | The small vesicular culprits: the investigation of extracellular vesicles as new targets for cancer treatment |
| Q41627477 | Two-tailed RT-qPCR: a novel method for highly accurate miRNA quantification |
| Q48225109 | Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet? |
| Q58565036 | Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal- from head & neck cancer and asymptomatic EBV-infections |
| Q57793799 | liqDB: a small-RNAseq knowledge discovery database for liquid biopsy studies |
Search more.